An experimental new drug is inspiring “cautious optimism” in researchers after its late-stage trials showed great success in reducing the progression and symptoms of Alzheimer’s disease. The drug is an antibody called BAN2401. An 18-month phase 2 trial involving 856 patients showed that the treatment greatly reduced development of new beta amyloid clusters in the brain, […]
The post Experimental Alzheimer’s Drug Stirs Hope After Early Trials Reduce Toxic Protein Clusters by 70% appeared first on Good News Network.
from Good News Network https://ift.tt/2OoDOy5
No comments:
Post a Comment